Literature DB >> 2835090

Binding of cholesterol and inhibitory peptide derivatives with the fusogenic hydrophobic sequence of F-glycoprotein of HVJ (Sendai virus): possible implication in the fusion reaction.

K Asano1, A Asano.   

Abstract

Specificity of the binding of sterols and related compounds with purified F-protein (fusion protein) of the HVJ (Sendai virus) was studied by binding competition with [3H]cholesterol. Requirement for cholesterol or the A/B ring trans structure and nonrequirement for the 3-hydroxyl group were found in this binding. Binding of 125I-labeled Z-Phe-Tyr, an inhibitory peptide of viral membrane-cell membrane fusion, was studied by using purified proteins and virions. F-Protein and virions showed a specific binding with the peptide, whereas the result was negative with hemagglutinin and neuraminidase protein. Thermolysin-truncated F-protein (an F-protein derivative deprived of a 2.5-kDa fragment from the N-terminal of the F1 subunit and without fusogenic activity) exhibited a considerably diminished binding ability both to cholesterol and to inhibitory peptides. Therefore, the N-terminal hydrophobic sequence that was previously assigned as fusogenic seems to be the binding site of these molecules. In support of this, the binding of cholesterol with F-protein was inhibited by Z-Phe-Tyr and other fusion inhibitory peptides, whereas it was not affected with non-fusion-inhibitory Z-Gly-Phe. These results are discussed in relation to the notion that the binding of the N-terminal portion of the F1 subunit of F-protein with cholesterol in the target cell membranes facilitates the fusion reaction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835090     DOI: 10.1021/bi00404a035

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Relationship of cholesterol content to spatial distribution and age of disc membranes in retinal rod outer segments.

Authors:  K Boesze-Battaglia; S J Fliesler; A D Albert
Journal:  J Biol Chem       Date:  1990-11-05       Impact factor: 5.157

Review 2.  Membrane fusion of enveloped viruses: especially a matter of proteins.

Authors:  D Hoekstra
Journal:  J Bioenerg Biomembr       Date:  1990-04       Impact factor: 2.945

3.  Biochemical consequences of a mutation that controls the cholesterol dependence of Semliki Forest virus fusion.

Authors:  P K Chatterjee; M Vashishtha; M Kielian
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Evaluation of the antiviral effect of synthetic oligopeptides whose sequences are derived from paramyxovirus F1 N termini.

Authors:  N M Inocencio; B Gotoh; T Toyoda; C Kitada; Y Nagai
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

5.  Cholesterol is required for the fusion of single unilamellar vesicles with Mycoplasma capricolum.

Authors:  M Tarshis; M Salman; S Rottem
Journal:  Biophys J       Date:  1993-03       Impact factor: 4.033

6.  The influenza virus ion channel and maturation cofactor M2 is a cholesterol-binding protein.

Authors:  Cornelia Schroeder; Harald Heider; Elisabeth Möncke-Buchner; Tse-I Lin
Journal:  Eur Biophys J       Date:  2004-06-25       Impact factor: 1.733

7.  Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes.

Authors:  R C Aloia; H Tian; F C Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

8.  Elucidation of the Rotavirus NSP4-Caveolin-1 and -Cholesterol Interactions Using Synthetic Peptides.

Authors:  Megan E Schroeder; Heather A Hostetler; Friedhelm Schroeder; Judith M Ball
Journal:  J Amino Acids       Date:  2012-03-01

Review 9.  Cholesterol-binding viral proteins in virus entry and morphogenesis.

Authors:  Cornelia Schroeder
Journal:  Subcell Biochem       Date:  2010

10.  Modulation of coronavirus-mediated cell fusion by homeostatic control of cholesterol and fatty acid metabolism.

Authors:  M Cervin; R Anderson
Journal:  J Med Virol       Date:  1991-10       Impact factor: 2.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.